Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MEPROBAMATE Cause Toxicity to various agents? 205 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 205 reports of Toxicity to various agents have been filed in association with MEPROBAMATE (Meprobamate). This represents 48.0% of all adverse event reports for MEPROBAMATE.

205
Reports of Toxicity to various agents with MEPROBAMATE
48.0%
of all MEPROBAMATE reports
183
Deaths
21
Hospitalizations

How Dangerous Is Toxicity to various agents From MEPROBAMATE?

Of the 205 reports, 183 (89.3%) resulted in death, 21 (10.2%) required hospitalization, and 1 (0.5%) were considered life-threatening.

Is Toxicity to various agents Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MEPROBAMATE. However, 205 reports have been filed with the FAERS database.

What Other Side Effects Does MEPROBAMATE Cause?

Drug abuse (74) Overdose (58) Completed suicide (53) Death (34) Drug dependence (30) Cardiac arrest (29) Accidental overdose (26) Impaired driving ability (25) Respiratory arrest (24) Road traffic accident (23)

What Other Drugs Cause Toxicity to various agents?

OXYCODONE (17,518) ACETAMINOPHEN (16,128) FENTANYL (15,546) MORPHINE (15,337) BUPRENORPHINE (10,906) HYDROMORPHONE (10,769) HYDROCODONE (10,645) ACETAMINOPHEN\OXYCODONE (10,568) ACETAMINOPHEN\HYDROCODONE (10,343) TAPENTADOL (9,617)

Which MEPROBAMATE Alternatives Have Lower Toxicity to various agents Risk?

MEPROBAMATE vs MERCAPTOPURINE MEPROBAMATE vs MEROPENEM MEPROBAMATE vs MEROPENEM ANHYDROUS MEPROBAMATE vs MESALAMINE MEPROBAMATE vs MESNA

Related Pages

MEPROBAMATE Full Profile All Toxicity to various agents Reports All Drugs Causing Toxicity to various agents MEPROBAMATE Demographics